Safety of human albumin as a constituent of biologic therapeutic products

被引：40

作者：

McClelland, DBL ^{[1
]}

机构：

[1] Royal Infirm, Edinburgh & SE Scotland Blood Transfus Serv, Edinburgh EH3 9HB, Midlothian, Scotland

来源：

TRANSFUSION | 1998年 / 38卷 / 07期

关键词：

D O I：

10.1046/j.1537-2995.1998.38798346639.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：690 / 699

页数：10

共 59 条

[1]

*ABPI, 1996, ABPI COMP DAT SHEETS

[2] Human BSE [J].

Almond, J ;

Pattison, J .

NATURE, 1997, 389 (6650) :437-438

[3] RECOVERY OF AUSTRALIA ANTIGEN FROM HUMAN PLASMA PRODUCTS SEPARATED BY A MODIFIED COHN FRACTIONATION [J].

BERG, R ;

BERNTSEN, K ;

BJORLING, H ;

ESPMARK, A .

VOX SANGUINIS, 1972, 22 (01) :1-&

[4]

BHATTACHARYA P, 1996, HAEMOPHILIA S1, V2, P23

[5] COMPARISON AND EVALUATION OF 9 BIBLIOGRAPHIC DATABASES CONCERNING ADVERSE DRUG-REACTIONS [J].

BIAREZ, O ;

SARRUT, B ;

DOREAU, CG ;

ETIENNE, J .

DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (10) :1062-1065

[6]

Castagna M., 1975, G IG MED PREV, V16, P3

[7] Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96 [J].

Cousens, SN ;

Zeidler, M ;

Esmonde, TF ;

DeSilva, R ;

Wilesmith, JW ;

Smith, PG ;

Will, RG .

BRITISH MEDICAL JOURNAL, 1997, 315 (7105) :389-395

[8]

*CPMP, 1998, CPMPBWP39097

[9] CREUTZFELDT-JAKOB-DISEASE AFTER LIVER-TRANSPLANTATION [J].

CREANGE, A ;

GRAY, F ;

CESARO, P ;

ADLEBIASSETTE, H ;

DUVOUX, C ;

CHERQUI, D ;

BELL, J ;

PARCHI, P ;

GAMBETTI, P ;

DEGOS, JD .

ANNALS OF NEUROLOGY, 1995, 38 (02) :269-272

[10]

CUTHBERTSON B, 1987, LANCET, V2, P41

← 1 2 3 4 5 6 →